Ownership

Versant Venture Capital VI, L.P.

Insider Reports History

Entity: Company
Location: One Sansome Street, Suite 1650, San Francisco, CA
Signature: Versant Venture Capital VI, L.P. By: Versant Ventures VI GP, L.P. Its: General Partner By: Versant Ventures VI GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Versant Venture Capital VI, L.P.:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Monte Rosa Therapeutics, Inc.	10%+ Owner	Common Stock	4.08M	$38.4M	$9.41	Oct 28, 2024	Direct
Black Diamond Therapeutics, Inc.	10%+ Owner	Common Stock	3.73M	$23.6M	$6.32	Aug 28, 2024	Direct
Century Therapeutics, Inc.	10%+ Owner	Common Stock	11.5M	$17.1M	$1.49	Aug 9, 2022	Direct
Monte Rosa Therapeutics, Inc.	10%+ Owner	Common Stock	1.57M	$14.8M	$9.41	Oct 29, 2024	Indirect
LENZ Therapeutics, Inc.	10%+ Owner	Common Stock	2.1M	$8.57M	$4.08	Mar 21, 2024	Direct
Contineum Therapeutics, Inc.	10%+ Owner	Class A Common Stock	376K	$6.4M	$17.05	Apr 9, 2024	Direct
Black Diamond Therapeutics, Inc.	10%+ Owner	Common Stock	822K	$5.2M	$6.32	Aug 28, 2024	Indirect
LENZ Therapeutics, Inc.	10%+ Owner	Common Stock	842K	$3.44M	$4.08	Mar 21, 2024	Indirect
Contineum Therapeutics, Inc.	10%+ Owner	Class A Common Stock	148K	$2.53M	$17.05	Apr 9, 2024	Indirect
Tempest Therapeutics, Inc.	10%+ Owner	Common Stock	2.12M	$2.33M	$1.10	Aug 8, 2024	Indirect
Century Therapeutics, Inc.	10%+ Owner	Common Stock	714K	$1.06M	$1.49	Aug 9, 2022	Indirect
Tempest Therapeutics, Inc.	10%+ Owner	Common Stock	210K	$231K	$1.10	Aug 12, 2024	Direct
LAVA Therapeutics NV	10%+ Owner	Common Shares	3.41M			Jan 1, 2025	Direct
Contineum Therapeutics, Inc.	10%+ Owner	Series B Preferred Stock	1.74M			Apr 9, 2024	Direct
Contineum Therapeutics, Inc.	10%+ Owner	Series A-1 Preferred Stock	1.42M			Apr 9, 2024	Direct
LAVA Therapeutics NV	10%+ Owner	Common Shares	1.18M			Jan 1, 2025	Indirect
Contineum Therapeutics, Inc.	10%+ Owner	Series C Preferred Stock	710K			Apr 9, 2024	Indirect
Contineum Therapeutics, Inc.	10%+ Owner	Series B Preferred Stock	435K			Apr 9, 2024	Indirect
Contineum Therapeutics, Inc.	10%+ Owner	Series A Preferred Stock	9.25K			Apr 9, 2024	Indirect
Oyster Point Pharma, Inc.	10%+ Owner	Common Stock	0		$11.20	Jan 3, 2023	Direct
Oyster Point Pharma, Inc.	10%+ Owner	Common Stock	0		$11.20	Jan 3, 2023	Indirect

Previous1Next

Showing 1 to 21 of 21 entries

Insider Reports Filed by Versant Venture Capital VI, L.P.

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
LVTX	LAVA Therapeutics NV	Jan 1, 2025	0	$0	3	Feb 6, 2025	10%+ Owner
GLUE	Monte Rosa Therapeutics, Inc.	Oct 28, 2024	13	-$1.49M	4	Oct 30, 2024	10%+ Owner
GLUE	Monte Rosa Therapeutics, Inc.	Sep 20, 2024	1	-$7.4M	4	Sep 24, 2024	10%+ Owner
GLUE	Monte Rosa Therapeutics, Inc.	Sep 11, 2024	3	-$3.4M	4	Sep 13, 2024	10%+ Owner
BDTX	Black Diamond Therapeutics, Inc.	Aug 28, 2024	1	-$1.4M	4	Aug 30, 2024	10%+ Owner
TPST	Tempest Therapeutics, Inc.	Aug 8, 2024	2	-$967K	4	Aug 12, 2024	10%+ Owner
CTNM	Contineum Therapeutics, Inc.	Apr 9, 2024	21	$0	4	Apr 11, 2024	10%+ Owner
CTNM	Contineum Therapeutics, Inc.	Apr 4, 2024	0	$0	3	Apr 4, 2024	10%+ Owner
LENZ	LENZ Therapeutics, Inc.	Mar 21, 2024	1	$0	4	Mar 25, 2024	10%+ Owner
OYST	Oyster Point Pharma, Inc.	Jan 3, 2023	4	$0	4	Jan 4, 2023	10%+ Owner
IPSC	Century Therapeutics, Inc.	Aug 9, 2022	2	-$7.17M	4	Aug 11, 2022	10%+ Owner
TPST	Tempest Therapeutics, Inc.	Apr 29, 2022	0	$0	4	May 3, 2022	10%+ Owner
IPSC	Century Therapeutics, Inc.	Jan 31, 2022	1	$0	4	Feb 2, 2022	10%+ Owner
OYST	Oyster Point Pharma, Inc.	Jan 5, 2022	4	$0	4	Jan 7, 2022	10%+ Owner
IPSC	Century Therapeutics, Inc.	Dec 23, 2021	1	$0	4	Dec 28, 2021	10%+ Owner
OYST	Oyster Point Pharma, Inc.	Dec 21, 2021	4	$0	4	Dec 23, 2021	10%+ Owner
OYST	Oyster Point Pharma, Inc.	Oct 18, 2021	4	-$8.16M	4	Oct 20, 2021	10%+ Owner
GRPH	Graphite Bio, Inc.	Jun 29, 2021	5	$3.06M	4	Jul 1, 2021	10%+ Owner
GLUE	Monte Rosa Therapeutics, Inc.	Jun 28, 2021	7	$3M	4	Jun 30, 2021	10%+ Owner
TPST	Tempest Therapeutics, Inc.	Jun 25, 2021	0	$0	3	Jul 6, 2021	10%+ Owner
GRPH	Graphite Bio, Inc.	Jun 24, 2021	0	$0	3	Jun 24, 2021	10%+ Owner
GLUE	Monte Rosa Therapeutics, Inc.	Jun 23, 2021	0	$0	3	Jun 23, 2021	10%+ Owner
IPSC	Century Therapeutics, Inc.	Jun 22, 2021	5	$2M	4	Jun 23, 2021	10%+ Owner
IPSC	Century Therapeutics, Inc.	Jun 17, 2021	0	$0	3	Jun 17, 2021	10%+ Owner
OYST	Oyster Point Pharma, Inc.	May 12, 2021	4	$0	4	May 14, 2021	10%+ Owner